AKBM — Aker Biomarine ASA Share News
0.000.00%
Last trade - 00:00- NOK10.70bn
- NOK12.48bn
- $218.10m
Brief: Aker Biomarine Successfully Completes New Bond Issue
Brief: Aker Biomarine Q2 Adjusted EBITDA Of $29.0 Million
Brief: Aker BioMarine Q1 Adjusted EBITDA USD 15.2 Million
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 17.6 Million Vs. IBES Estimate USD 20 Million
Brief: Aker Biomarine Receives Purchase Order
Brief: Aker Biomarine Q3 Adjusted EBITDA At USD 24.9 Mln
Brief: Aker Biomarine Acquires Patents, Equipment, And Scientific Data From Acasti Pharma
Brief: Aker Biomarine: Update On The Krill Harvesting For 2023
Brief: Krill Oil Receives Approval Of Health Claim In Australia
Brief: Aker Biomarine Receives Approval For Lysovetatm As New Dietary Ingredient In The US
Brief: Aker BioMarine Q2 Adjusted EBITDA USD 21.5 Million
Brief: Aker Biomarine Gets Receipt Of Approval Of Superba Krill Oil In Korean Market
Brief: Aion Enters Collaboration With Microsoft Norway
Brief: Aker Biomarine Expects Long-Term Average Annual Sales Growth At Around 15%
Brief: Aker BioMarine Q1 Adj. EBITDA at USD 6 Million
Brief: Aker Biomarine Expects South Korea To Approve Superba Krill Oil
Brief: Company Related To Aker Biomarine Chairman Buys Shares
Brief: Aker BioMarine Q4 Revenue Misses Analyst Expectations
Brief: Aker Biomarine Product Mainly Containing Superba Krill Oil Is Approved In South Korea